Can Systemic Anti-CD20 B Cell-Depleting Antibodies Eliminate Meningeal Follicles in Multiple Sclerosis?
Neurol Neuroimmunol Neuroinflamm
.
2021 May 17;8(4):e1000.
doi: 10.1212/NXI.0000000000001000.
Print 2021 Jul.
Authors
Sasha Gupta
1
,
Scott S Zamvil
1
Affiliation
1
From the Department of Neurology, Weill Institute of Neurosciences and Program in Immunology, University of California, San Francisco, CA. sasha.gupta@ucsf.edu zamvil@ucsf.neuroimmunol.org.
PMID:
34001659
PMCID:
PMC8130009
DOI:
10.1212/NXI.0000000000001000
No abstract available
Publication types
Editorial
Comment
MeSH terms
Antibodies, Monoclonal
B-Lymphocytes
Humans
Multiple Sclerosis* / drug therapy
Substances
Antibodies, Monoclonal
Grants and funding
R01 AI131624/AI/NIAID NIH HHS/United States